Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 8.01, 9.01 · 8-K

CQENS Technologies Inc.

Other Events

Item 8.01 Other Events. On September 30, 2020, CQENS Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (the “IP Asset Purchase Agreement”) with Xten Capital Group, Inc., a related party (“Xten”), pursuant to which it acquired a portfolio of 29 U.S.…

Filed Sep 3, 2026Accepted Sep 3, 2026, 5:06 PM EDTCIK 1479915Accession 0001493152-26-041396
Share

Recent company filings

  1. 10-Q filingAug 19, 2026
  2. NT 10-Q filingAug 13, 2026
  3. 10-Q filingMay 14, 2026
  4. 10-K filingApr 15, 2026
  5. NT 10-K filingMar 31, 2026

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On September 30, 2020, CQENS Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (the “IP Asset Purchase Agreement”) with Xten Capital Group, Inc., a related party (“Xten”), pursuant to which it acquired a portfolio of 29 U.S. and international patents and patent applications in the areas of devices and technologies for aerosolizing certain remedies and pharmaceutical preparations, as well as the solutions and preparation for inhaled delivery. As consideration for the acquisition, the Company issued Xten common stock purchase warrants exercisable for an aggregate of 21,000,000 shares of its common stock at an exercise price of $5.31 per share (the “Warrants”), including a Series A Common Stock Purchase Warrant (the “Series A Warrant”) exercisable for 7,000,000 shares of common stock commencing on September 30, 2023 and expiring on September 30, 2026, and a Series B Common Stock Purchase Warrant (the “Series B Warrant”) exercisable for 7,000,000 shares of common stock commencing on September 30, 2026 and expiring on September 30, 2029, and a Series C Common Stock Purchase Warrant exercisable for 7,000,000 shares of common stock commencing on September 30, 2029 and expiring on September 30, 2032. On September 3, 2026, the Company approved an amendment to modify the Series A Warrants and Series B Warrants (the “Amendment”). Pursuant to this Amendment, Xten agreed to modify and delay the exercise period of the Series B Warrant to now commence on September 30, 2029 and expire on September 30, 2032. In exchange for Xten’s agreement to delay the exercise period of the Series B Warrant, the Company agreed to amend the exercise period of the Series A Warrant from September 30, 2023 through September 30, 2026 to September 30, 2029 through September 30, 2032. Except as described above, there have been no other modifications to the Series A Warrant or the Series B Warrant and all other terms of such warrants remain unchanged and in full force and effect. The foregoing description of the Amendment is not complete and is qualified in its entirety by reference to the full text of the Exhibit filed as Exhibit 4.1, which is incorporated by reference into this Item 8.01.
Filed exhibits (1)
EX-4.1 (by filename) ex4-1.htm

EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 AGREEMENT OF AMENDMENT TO THE SERIES A AND SERIES B COMMON STOCK PURCHASE WARRANTS OF CQENS TECHNOLOGIES INC. This amendment to both the Series A and Series B Common Stock Purchase Warrants of CQENS Technologies Inc. (“ Amendment ”) is dated as of September 3, 2026 (the “ Effective Date ”), by and between CQENS Technologies Inc., a Delaware corporation (the “ Company ”) and Xten Capital Group, Inc., a Minnesota corporation (the “ Holder ”). Company and the Holder are sometimes individually referred to herein as a “Party” or collectively referred to herein as the “Parties.” RECITALS WHEREBY, the Parties previously entered into that certain Series A and Series B Common Stock Purchase Warrants of CQENS Technologies Inc. (the “ Warrants ”) and WHEREBY, the Parties desire to amend the Warrants pursuant to the terms and conditions of this Amendment and the Board of Directors of the Company has approved this Amendment to be effective as of the date hereof. AGREEMENT NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and conditions set forth below, and for other good and valuable consideration, the receipt a…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.